The final cohort of patients has been dosed in Cybin’s Dosing Phase 2 Trial investigating CYB003 – an investigational deuterated analogue of psilocybin – as a...
Dimethyltryptamine (DMT) is a naturally occurring psychedelic compound found in many plants and some animals.
Alcohol use disorders (AUD) are estimated to affect around 237 million people across the globe, with 3 million deaths each year attributed to the harmful use...
As hypothesised with cannabis, could the ‘entourage effect’ play a role in the therapeutic effects of psilocybin mushrooms?
MGC Pharmaceuticals has received permission to import psilocybin into Slovenia.
Kernel has published results from its Cybin-sponsored neuroimaging study which show the ability of Kernel’s Flow1 system to capture and analyse brain changes induced by psychedelics.
Adaptogens are herbs, roots and other plant substances (like mushrooms) that help our bodies manage stress and restore balance after a stressful situation.
A low-cost version of ketamine has shown promising results in its treatment of resistant depression in a double-blind trial.
As their 300-gram MDMA shipment got to the border, PharmAla Biotech found themselves in a sticky situation.
The Psychedelic Access and Research Alliance (PAREA) has released a position statement calling on the EU to harness psychedelics in a bid to create innovation in...
A group of doctors are urging researchers to look at psychedelics to ease the often overwhelming distress faced by women with late-stage gynaecological cancers.
For thousands of years, indigenous societies in Mexico and Central America have used psychedelics for medicinal, spiritual, and cultural purposes.